Synonyms: GENZ-112638
eliglustat is an approved drug (FDA (2014), EMA (2015))
Compound class:
Synthetic organic
Comment: The marketed formulation contains eliglustat tartrate (PubChem CID 52918379).
|
|
Bioactivity Comments |
Eliglustat inhibits the production of glucosylceramide in Madin-Darby canine kidney (MDCK) cells with an IC50 of 13.7nM [1]. |